Jupiter Orphan Therapeutics, Inc. logo

Jupiter Orphan Therapeutics, Inc.

Jupiter Orphan Therapeutics is devoted to the development of clinical stage drugs for the treatment of rare diseases.

5

Funding Rounds

$6.4m

Money raised

Overview

Jupiter Orphan Therapeutics is devoted to the development of clinical stage drugs for the treatment of rare diseases.

Funding series

Funding Series Analysis

The company Jupiter Orphan Therapeutics, Inc. has raised a total of $2.5m in funding over 5 rounds.

Key Insights:

  • Jupiter Orphan Therapeutics, Inc. , January 2017: $2.5m
  • Jupiter Orphan Therapeutics, Inc. Seed round, January 2015: $2.5m
  • Jupiter Orphan Therapeutics, Inc. Seed round, July 2016: $250k
  • Jupiter Orphan Therapeutics, Inc. funding round, December 2017: $100k
  • Jupiter Orphan Therapeutics, Inc. funding round, December 2016: $1m
Jupiter Orphan Therapeutics, Inc. logo
Jupiter Orphan Therapeutics, Inc. , January 2017 $2.5m
Jupiter Orphan Therapeutics, Inc. logo
Jupiter Orphan Therapeutics, Inc. Seed round, January 2015 $2.5m
Jupiter Orphan Therapeutics, Inc. logo
Jupiter Orphan Therapeutics, Inc. Seed round, July 2016 $250k
Jupiter Orphan Therapeutics, Inc. logo
Jupiter Orphan Therapeutics, Inc. funding round, December 2017 $100k
Jupiter Orphan Therapeutics, Inc. logo
Jupiter Orphan Therapeutics, Inc. funding round, December 2016 $1m

Industries

Jupiter Orphan Therapeutics, Inc. is active in the following industries: